SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-000829
Filing Date
2019-03-19
Accepted
2019-03-19 17:00:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D sc13da410959006_03192019.htm SC 13D/A 103597
  Complete submission text file 0000921895-19-000829.txt   105190
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42745 | Film No.: 19692123
SIC: 2834 Pharmaceutical Preparations

Mailing Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168 212-302-0699
BP Peptides, LLC (Filed by) CIK: 0001711689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A